-
Ann Bartling joins Health Unlimited in new PR practice lead position
21 May 2018 10:19 GMT
… Door Unlimited and US agency Cooney Waters Unlimited.
Tim Bird, CEO of …
-
KemPharm to Present at Canaccord Genuity 36th Annual Growth Conference
28 Jul 2016 12:02 GMT
… .com
Media Contact:
Jim Heins
Cooney Waters Unlimited
212-886-2221
jheins …
-
KemPharm Completes Key Regulatory Meetings with FDA for KP201/IR and KP415
14 Jul 2016 20:10 GMT
… .com
Media Contact:
Jim Heins
Cooney Waters Unlimited
212-886-2221
jheins …
-
KemPharm’s Prodrug of Hydromorphone, KP511, Demonstrates Comparable Oral Pharmacokinetics to Hydromorphone in Phase 1 Trial
28 Jun 2016 20:15 GMT
… .com
Media Contact:
Jim Heins
Cooney Waters Unlimited
212-886-2221
jheins …
-
FDA Issues Complete Response Letter for Apadaz™ New Drug Application
13 Jun 2016 20:15 GMT
… .com
Media Contact:
Jim Heins
Cooney Waters Unlimited
212-886-2221
jheins …
-
KemPharm Files NDA Amendment Request with FDA for Apadaz™
09 Jun 2016 10:55 GMT
… .com
Media Contact:
Jim Heins
Cooney Waters Unlimited
212-886-2221
jheins …
-
KemPharm to Present Data from Pharmacokinetic Trial for Investigational Prodrug Benzhydrocodone at the 2016 International Conference on Opioids
06 Jun 2016 12:05 GMT
… .com
Media Contact:
Jim Heins
Cooney Waters Unlimited
212-886-2221
jheins …
-
KemPharm, Inc. to Host Annual Meeting of Stockholders on Tuesday, May 24, 2016 at 9:00 a.m. ET
18 May 2016 21:17 GMT
… .com
Media Contact:
Jim Heins
Cooney Waters Unlimited
212-886-2221
jheins …
-
KemPharm, Inc. Reports First Quarter 2016 Results
12 May 2016 20:05 GMT
… .com
Media Contact:
Jim Heins
Cooney Waters Unlimited
212-886-2221
jheins …
-
KemPharm Receives “Fast Track” Designation for KP511, an Investigational Prodrug of Hydromorphone
10 May 2016 12:30 GMT
… .com
Media Contact:
Jim Heins
Cooney Waters Unlimited
212-886-2221
jheins …